Evidence map›Paper›PMID 27452860›Full record

ArticleScientific reports2016

Oral CoQ10 attenuates high salt-induced hypertension by restoring neurotransmitters and cytokines in the hypothalamic paraventricular nucleus.

Hong-Li Gao, Xiao-Jing Yu, Jie Qi, Qiu-Yue Yi, Wang-Hui Jing, Wen-Yan Sun, Wei Cui, Jian-Jun Mu, Zu-Yi Yuan, Xiu-Fang Zhao and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Oxidative Stress, Antioxidants and Hypertension.Antioxidants (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. The Use of Coenzyme Q10 in Cardiovascular Diseases.Antioxidants (Basel, Switzerland) · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Hong-Li GaoDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Xiao-Jing YuDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Jie QiDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Qiu-Yue YiDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Wang-Hui JingDepartment of Pharmaceutical Analysis, School of Pharmacy, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Wen-Yan SunDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Wei CuiDepartment of Endocrinology and Metabolism, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Jian-Jun MuDepartment of Cardiology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an 710061, China.
Zu-Yi YuanDepartment of Cardiology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an 710061, China.
Xiu-Fang ZhaoDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Kai-Li LiuDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Guo-Qing ZhuDepartment of Physiology, Nanjing Medical University, Nanjing 210029, China.
Xiao-Lian ShiDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Jin-Jun LiuDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Yu-Ming KangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Cardiovascular Research Center, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Xi'an Jiaotong University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High salt intake leads to an increase in some proinflammatory cytokines and neurotransmitters involved in the pathogenesis of hypertension. The purpose of this work was to know if oral administration of anti-oxidant and free-radical scavenger CoQ10 may attenuate high salt-induced hypertension via regulating neurotransmitters and cytokines in the hypothalamic paraventricular nucleus (PVN). Adult male Sprague-Dawley (SD) rats were fed with a normal salt diet (NS, 0.3% NaCl) or a high salt diet (HS, 8% NaCl) for 15 weeks to induce hypertension. These rats received CoQ10 (10 mg/kg/day) dissolved in olive oil was given by gavage (10 mg/kg/day) for 15 weeks. HS resulted in higher mean arterial pressure (MAP) and the sympathetic nerve activity (RSNA). These HS rats had higher PVN levels of norepinephrine (NE), tyrosine hydroxylase (TH), interleukin (IL)-1β, NOX2 and NOX4, lower PVN levels of gamma-aminobutyric acid (GABA), IL-10, copper/zinc superoxide dismutase (Cu/Zn-SOD) and the 67-kDa isoform of glutamate decarboxylase (GAD67), as compared with NS group. CoQ10 supplementation reduced NE, TH, IL-1β, NOX2 and NOX4 in the PVN, and induced IL-10, Cu/Zn-SOD and GAD67 in the PVN. These findings suggest that CoQ10 supplementation restores neurotransmitters and cytokines in the PVN, thereby attenuating high salt-induced hypertension.

Indexed as

AnimalsAntioxidantsFree Radical ScavengersGene Expression RegulationHumansHypertensionInterleukin-1betaNADPH Oxidase 2Neurotransmitter AgentsNorepinephrineParaventricular Hypothalamic NucleusRatsSaltsSuperoxide Dismutase-1Tyrosine 3-MonooxygenaseUbiquinoneAntioxidantscoenzyme Q10Cybb protein, ratFree Radical ScavengersIL1B protein, ratInterleukin-1betaNADPH Oxidase 2Neurotransmitter AgentsNorepinephrineSaltsSuperoxide Dismutase-1Tyrosine 3-MonooxygenaseUbiquinone

Identifiers

PMID27452860
PMCPMC4958989
OpenAlexW2489356282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.